Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for CorMedix (CRMD) over the last 12 years, with Q3 2025 value amounting to 0.28%.

  • CorMedix's Return on Capital Employed rose 12100.0% to 0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28%, marking a year-over-year increase of 12100.0%. This contributed to the annual value of 0.52% for FY2022, which is 300.0% up from last year.
  • Latest data reveals that CorMedix reported Return on Capital Employed of 0.28% as of Q3 2025, which was up 12100.0% from 0.29% recorded in Q2 2025.
  • In the past 5 years, CorMedix's Return on Capital Employed registered a high of 0.29% during Q2 2025, and its lowest value of 1.05% during Q2 2024.
  • For the 5-year period, CorMedix's Return on Capital Employed averaged around 0.44%, with its median value being 0.48% (2022).
  • As far as peak fluctuations go, CorMedix's Return on Capital Employed crashed by -3000bps in 2024, and later soared by 13400bps in 2025.
  • CorMedix's Return on Capital Employed (Quarter) stood at 0.44% in 2021, then fell by -25bps to 0.55% in 2022, then decreased by -14bps to 0.63% in 2023, then soared by 45bps to 0.35% in 2024, then soared by 181bps to 0.28% in 2025.
  • Its Return on Capital Employed stands at 0.28% for Q3 2025, versus 0.29% for Q2 2025 and 0.14% for Q1 2025.